Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sutter

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Optometry (St. Louis, Mo.)|April 19, 2005
A commonsense approach to the HIPAA security regulationToni G Sutter
Advances in Virus Research|January 7, 2017
Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine DevelopmentA Volz, G Sutter
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1992
Nonreplicating vaccinia vector efficiently expresses recombinant genesG Sutter, B Moss
AIDS (London, England)|January 31, 2002
Novel vaccine delivery systems: solutions to HIV vaccine dilemmas?G Sutter, J Haas
Developments in Biological Standardization|January 1, 1995
Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virusG Sutter, B Moss
Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994
A cellular factor is required for transcription of vaccinia viral intermediate-stage genesR Rosales, G Sutter, B Moss
The Journal of General Virology|May 1, 1991
Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulenceH Meyer, G Sutter, A Mayr
FEBS Letters|August 28, 1995
Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymeraseG Sutter, M Ohlmann, V Erfle
Plant Physiology|August 1, 1992
Measurement of indolebutyric Acid in plant tissues by isotope dilution gas chromatography-mass spectrometry analysisE G Sutter, J D Cohen
Journal of Clinical Psychology|November 1, 1986
Factor structure of the WISC-R and ITPA for learning-disabled, emotionally disturbed, and control childrenE G Sutter, P C Bishop
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Optometry (St. Louis, Mo.)|April 19, 2005
A commonsense approach to the HIPAA security regulationToni G Sutter
Advances in Virus Research|January 7, 2017
Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine DevelopmentA Volz, G Sutter
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1992
Nonreplicating vaccinia vector efficiently expresses recombinant genesG Sutter, B Moss
AIDS (London, England)|January 31, 2002
Novel vaccine delivery systems: solutions to HIV vaccine dilemmas?G Sutter, J Haas
Developments in Biological Standardization|January 1, 1995
Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virusG Sutter, B Moss
Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994
A cellular factor is required for transcription of vaccinia viral intermediate-stage genesR Rosales, G Sutter, B Moss
The Journal of General Virology|May 1, 1991
Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulenceH Meyer, G Sutter, A Mayr
FEBS Letters|August 28, 1995
Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymeraseG Sutter, M Ohlmann, V Erfle
Plant Physiology|August 1, 1992
Measurement of indolebutyric Acid in plant tissues by isotope dilution gas chromatography-mass spectrometry analysisE G Sutter, J D Cohen
Journal of Clinical Psychology|November 1, 1986
Factor structure of the WISC-R and ITPA for learning-disabled, emotionally disturbed, and control childrenE G Sutter, P C Bishop
Pageof 8